The Role of Gene Changes in Brain Tumor Formation and Growth
Glioma
About this trial
This is an observational trial for Glioma focused on measuring Glioma, Brain Tumor, Epidermal Growth Factor, Polymorphisms
Eligibility Criteria
INCLUSION CRITERIA: Radiographic evidence of a primary glial neoplasm of the CNS (WHO grade II-IV) or any patient with known primary neoplasms of the CNS. Medically indicated diagnostic and/or therapeutic tumor resection. Informed consent from patient, age 18 or older to 75 years of age. Females of child-bearing capacity: Pregnant women will be entered into the study for tumor collection, but blood will not be drawn at the time of surgery. Six weeks or more after the completion of pregnancy, these women will be contacted and 10cc (2 tsp) of blood will be collected for genotyping. No racial or ethnic group or gender is excluded. EXCLUSION CRITERIA: Inability to provide informed consent prior to surgery. Medical conditions that cannot be corrected prior to surgery that would be standard contraindications for neurosurgery.
Sites / Locations
- National Institute of Neurological Disorders and Stroke (NINDS)